1-3 of 3
Karen Hande
Close
Sort by
Journal Articles

Clinical, Radiographic, and Biomarker Characterization of Multiple Myeloma Patients with Bisphosphonate Associated Osteonecrosis of the Jaw.

Noopur Raje, MD, Sook-Bin Woo, Karen Hande, Jeffrey T. Yap, Paul G. Richardson, MD, Sonia Vallet, Nathaniel Treister, Teru Hideshima, Yu-Tzu Tai, Shweta Chhetri, Brendan Connell, Agnieszka Szot-Barnes, Mei Tian, Robert L. Schlossman, Edie Weeler, Nikhil C. Munshi, Annick D. Van Den Abbeele, Kenneth C. Anderson
Journal: Blood
Blood (2006) 108 (11): 3591.
https://doi.org/10.1182/blood.V108.11.3591.3591
Published: 2006
Journal Articles

Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM).

Paul G. Richardson, Asher Chanan-Khan, Robert L. Schlossman, Nikhil C. Munshi, Patrick Wen, Hannah Briemberg, David Kuter, Anne-Louise Oaklander, Sagar Lonial, Hani Hassoun, Deborah Doss, Kathleen Colson, Mary McKenney, Karen Hande, Alexandra Koryzna, Barbara Stoklas, Laura Lunde, Svetlana Gorelik, Cliona McAlister, Andrea Freeman, Diane Warren, Denise Collins, Dixie Esseltine, Anthony Amato, Kenneth C. Anderson
Journal: Blood
Blood (2004) 104 (11): 336.
https://doi.org/10.1182/blood.V104.11.336.336
Published: 2004
Journal Articles

Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, MD, Robert L. Schlossman, MD, Constantine S. Mitsiades, MD, PhD, Nikhil C. Munshi, MD, Kathleen Colson, Deborah Doss, Mary McKenney, Karen Hande, Svetlana Gorelik, Laura Lunde, Anna Stepanek, Andrea Freeman, Karyn Dinand, Stephen Hayes, Reggie Michelle, Keith Doucet, Diane Warren, Nicholas Mitsiades, MD, PhD, Victoria M. Richon, PhD, Judi Chiao, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 1503.
https://doi.org/10.1182/blood.V104.11.1503.1503
Published: 2004